The Bull Rankings scorecard — our quality-growth score is 56.9 / 100, built from three pillars scored 0–100: Quality 78, Growth 73, Value 32 (valuation is judged against sector peers). At today's price, our reverse-DCF read says the market is implicitly betting on free-cash-flow growth of about 14% a year next year, fading to 3% a year by year ten — a gauge of how much optimism is already in the stock.
The thesis
Nordson’s quality‑growth score of 56.9 is anchored by a 78‑point Quality pillar, a 73‑point Growth pillar, and a 32‑point Value pillar. The quality edge is the story we chase. A profit margin of 18.6% and ROE of 17% demonstrate that the company turns capital into cash efficiently. The $17.2 b company trades at a P/E of 31.2, and our reverse‑DCF says the price implies ~14%/yr free‑cash‑flow growth. That implied growth is double the 7% FY YoY revenue growth. In other words, the price is optimistic but not over‑ambitious. The bullish signal—raising its dividend—reinforces the narrative that cash is plentiful and the business is mature enough to reward shareholders.
What the business actually is
Nordson engineers, manufactures, and markets systems that dispense, apply, and control a wide range of fluids: adhesives, coatings, polymers, sealants, biomaterials, and medical components. The Industrial Precision Solutions segment supplies dispensing, coating, and laminating systems for adhesives, lotions, liquids, and fibers to disposable products and roll goods. It also offers automated adhesive dispensing systems, components for thermoplastic and biopolymer melt streams, fluid components such as nozzles, pumps, and filters, smart components that measure and control flow, and control systems for product assembly. Its Medical and Fluid Solutions segment makes components for medical device makers, and Advanced Technology Solutions sells test, inspection, and dispensing equipment for electronics. Together they serve customers from packaging to medical device manufacturers, giving Nordson a broad revenue engine.
Why it can (and does) keep compounding
The moat is built on technology and integration. Smart components that measure and control flow give Nordson a data advantage that competitors must replicate with significant R&D. The company’s free‑cash‑flow of $724 m and debt‑to‑equity of 0.56 allow it to fund growth without diluting shareholders. Its beta of 0.97 indicates that the stock moves roughly with the market. The model’s raising its dividend signal shows that the business can sustain payouts while still investing in new product lines.
The valuation question
At $308.31 the stock trades near its 52‑week high of $339.12 but still below the analyst consensus target of $349.71. The P/E of 31.2 is higher than the sector average, reflecting the market’s expectation of continued growth. Our reverse‑DCF tells us that the current price implies a 14%/yr free‑cash‑flow growth (in year one, slowing to 3% a year by year ten). Compared to the 7% revenue growth and the 18.6% margin, the implied growth is modestly optimistic but not outlandish. The PEG ratio of 1.79 says the multiple runs well ahead of the earnings growth analysts expect. In short, the market is betting that Nordson will maintain its margin discipline while expanding its revenue base, a bet that is already partially priced but still leaves room for upside if the company outpaces the 7% revenue growth.
The bear case
Value is the weakest pillar at 32, suggesting that the stock is expensive relative to peers. A single risk is that the debt‑to‑equity of 0.56 could rise if the company takes on more leverage to fund acquisitions or capital expenditures. If debt climbs, the free‑cash‑flow margin could compress, eroding the 18.6% profit margin that has been the backbone of Nordson’s quality story. A deterioration in margin would also make the 14% growth the price implies harder to reach.
What would change our mind
- Revenue growth falling below 5% would signal that the business is not growing fast enough to support the price.
- Profit margin slipping below 15% would erode the quality advantage and hurt free‑cash‑flow.
- Debt‑to‑equity rising above 1.0 would raise leverage concerns and could trigger a downgrade in analyst sentiment.
If any of these thresholds are breached, the current thesis would need to be revisited.